Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. [electronic resource]
Producer: 20120716Description: 521-36 p. digitalISSN:- 1879-114X
- Animals
- Antibodies, Monoclonal -- pharmacokinetics
- Antibodies, Monoclonal, Humanized
- Bone Density -- drug effects
- Bone Remodeling -- drug effects
- Bone and Bones -- drug effects
- Clinical Trials as Topic
- Denosumab
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Estrogens -- deficiency
- Female
- Humans
- Osteoporosis -- drug therapy
- Osteoporosis, Postmenopausal -- drug therapy
- RANK Ligand -- antagonists & inhibitors
- Testosterone -- deficiency
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.